Advertisement
U.S. markets open in 1 hour 56 minutes
S&P Futures
6,014.25 +27.25 (+0.46%) Dow Futures
44,658.00 +263.00 (+0.59%) Nasdaq Futures
20,958.25 +108.50 (+0.52%) Russell 2000 Futures
2,432.60 +19.00 (+0.79%) Crude Oil
71.13 -0.11 (-0.15%) Gold
2,683.90 -28.30 (-1.04%)
Ikena Oncology, Inc. (IKNA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 82.52M |
| Enterprise Value | -47.12M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 124.97 |
| Price/Book (mrq) | 0.61 |
| Enterprise Value/Revenue | 0.93 |
| Enterprise Value/EBITDA | -0.54 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.49 |
| 52-Week Change 3 | 6.21% |
| S&P500 52-Week Change 3 | 31.18% |
| 52 Week High 3 | 2.3200 |
| 52 Week Low 3 | 1.2200 |
| 50-Day Moving Average 3 | 1.7077 |
| 200-Day Moving Average 3 | 1.5814 |
Share Statistics
| Avg Vol (3 month) 3 | 53.04k |
| Avg Vol (10 day) 3 | 71.5k |
| Shares Outstanding 5 | 48.26M |
| Implied Shares Outstanding 6 | 48.26M |
| Float 8 | 13.87M |
| % Held by Insiders 1 | 10.49% |
| % Held by Institutions 1 | 63.58% |
| Shares Short (Oct 31, 2024) 4 | 129.88k |
| Short Ratio (Oct 31, 2024) 4 | 3.02 |
| Short % of Float (Oct 31, 2024) 4 | 0.34% |
| Short % of Shares Outstanding (Oct 31, 2024) 4 | 0.27% |
| Shares Short (prior month Sep 30, 2024) 4 | 207.13k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Sep 30, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -9,755.24% |
Management Effectiveness
| Return on Assets (ttm) | -22.06% |
| Return on Equity (ttm) | -37.08% |
Income Statement
| Revenue (ttm) | 659k |
| Revenue Per Share (ttm) | 0.01 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -63.58M |
| Net Income Avi to Common (ttm) | -59.6M |
| Diluted EPS (ttm) | -1.2300 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 138.03M |
| Total Cash Per Share (mrq) | 2.86 |
| Total Debt (mrq) | 8.39M |
| Total Debt/Equity (mrq) | 6.25% |
| Current Ratio (mrq) | 15.32 |
| Book Value Per Share (mrq) | 2.78 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -61.56M |
| Levered Free Cash Flow (ttm) | -43.97M |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.